BridgeMD
New treatment option for Neurological Impairments
Official title Speech Therapy and Parenting for Early Socio-communicAtive sKills
ClinicalTrials.gov ID: NCT06666777
What this study is testing
- What it's testing
- Every year, millions of children are diagnosed with neurodevelopmental disabilities. This term covers a wide range of conditions, from genetic syndromes to brain injuries such as cerebral palsy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 59
You may be able to join if
- For children:
- Age between 6 months (corrected age in cases of prematurity) and 5 years.
- Documented developmental delay and/or socio-communicative difficulties, based on clinical signs or standardized developmental scales (e.g., Griffiths...
- Mental age of at least 6 months.
- Diagnosis of neurodevelopmental disability, including cerebral palsy, genetic syndromes, rare diseases with non-progressive neurological impairments...
You likely can't join if
- For children:
- Age greater than 5 years at the time of recruitment.
- Mental age below 6 months.
- Absence of developmental delay (developmental quotient \> 85) and socio-communicative difficulties.
- Diagnosis of neurodevelopmental disability resulting from neurodegenerative diseases or brain tumor outcomes.
- Severe sensory impairments (profound deafness and/or blindness). For Parents:
See the full eligibility criteria
- For children:
- Age between 6 months (corrected age in cases of prematurity) and 5 years.
- Documented developmental delay and/or socio-communicative difficulties, based on clinical signs or standardized developmental scales (e.g., Griffiths Scales).
- Mental age of at least 6 months.
- Diagnosis of neurodevelopmental disability, including cerebral palsy, genetic syndromes, rare diseases with non-progressive neurological impairments, or congenital disorders of undetermined nature. For parents:
- Adult age (≥ 18 yo)
- Good knowledge and fluency in Italian.
- No manifest psychiatric conditions.
- No documented intellectual disability.
- For children:
- Age greater than 5 years at the time of recruitment.
- Mental age below 6 months.
- Absence of developmental delay (developmental quotient \> 85) and socio-communicative difficulties.
- Diagnosis of neurodevelopmental disability resulting from neurodegenerative diseases or brain tumor outcomes.
- Severe sensory impairments (profound deafness and/or blindness). For Parents:
- Inability to speak Italian.
- Documented psychiatric conditions or intellectual disability.
The study team makes the final eligibility decision.
Where it's taking place
- Como, Como, Italy
- Ponte Lambro, Como, Italy
- Bosisio Parini, Lecco, Italy
- Lecco, Lecco, Italy
- Sesto San Giovanni, Milano, Italy
- Carate Brianza, Monza E Brianza, Italy
- Cislago, Varese, Italy
- Vedano Olona, Varese, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 59 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Como, Como, Italy; Ponte Lambro, Como, Italy; Bosisio Parini, Lecco, Italy; Lecco, Lecco, Italy; Sesto San Giovanni, Milano, Italy; Carate Brianza, Monza E Brianza, Italy and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.